Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Human Genome Sciences Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 20
» View ktuu.com items only
    Jun 2, 2013 |Story| Los Angeles Times

  1. Letters: More on bioterrorism

    Re "Raising an alarm — and his income," May 19 Your article alleging that I didn't adequately reveal a conflict of interest doesn't mention that the "About the Author" page of my 2003 bioterrorism report explicitly stated that I was "a director of...

    Tags: Anthrax, Bioterrorism, Science and Technology

    2. May 30, 2013 |Story| Baltimore Sun

  2. Glaxo anti-cancer cocktail gets regulatory approval

    <span>After her melanoma, Cheryl Stratos is mostly back to a normal life, running a business and driving her teenage son to weekend events, but there are reminders that it could all come back: The sores all over her body, the high fevers, the hair loss -- even the possibility of a suddenly shortened life. For Stratos, of Virginia, and others who have benefitted from a class of revolutionary anti-cancer drugs known as BRAF mutation inhibitors, another tool in the fight against relapse has just been sharpened: Drug maker GlaxoSmithKline received FDA </span><a href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm354199.htm"><span>approval</span></a><span> Wednesday for a new cocktail that includes a BRAF-targeting component. </span>
    The Baltimore Sun
    After her melanoma, Cheryl Stratos is mostly back to a normal life, running a business and driving her teenage son to weekend events, but there are reminders that it could all come back: The sores all over her body, the high fevers, the hair loss --...

    Tags: Rockville (Bethlehem, Pennsylvania), Health Organizations, Food and Drug Administration, Oncology, American Cancer Society

    3. May 22, 2013 |Story| Los Angeles Times

  3. Bioterrorism consultant's anthrax claims challenged

    WASHINGTON &mdash; As an example of the ease with which terrorists could produce anthrax, former Navy Secretary Richard J. Danzig has repeatedly cited the Japanese cult Aum Shinrikyo.
    WASHINGTON — As an example of the ease with which terrorists could produce anthrax, former Navy Secretary Richard J. Danzig has repeatedly cited the Japanese cult Aum Shinrikyo. The cult gained infamy in 1995 by unleashing the nerve agent sarin in...

    Tags: Terrorism, Anthrax, Japan, Science and Technology, Bioterrorism

    4. May 19, 2013 |Story| Los Angeles Times

  4. Pointing to threat, pulling in profit

    Tribune Washington Bureau
    WASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...

    Tags: Defense, National Government, Terrorism, Rockville (Bethlehem, Pennsylvania), National Institutes of Health

    5. May 19, 2013 |Story| Los Angeles Times

  5. Timeline: An attorney and anthrax

    May 2001: Washington lawyer Richard J. Danzig is appointed to the board of Human Genome Sciences Inc. in Rockville, Md. Sept. 11, 2001: Terrorists crash passenger jets into the World Trade Center in New York, the Pentagon and rural Pennsylvania. Soon...

    Tags: Rockville (Bethlehem, Pennsylvania), Anthrax, U.S. Congress, GlaxoSmithKline PLC

    6. May 19, 2013 |Story| Los Angeles Times

  6. Spotlighting a terrorism risk, and profiting

    WASHINGTON &mdash; Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a major threat to national security.
    WASHINGTON — Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he...

    Tags: Defense, National Government, Rockville (Bethlehem, Pennsylvania), Terrorism, National Institutes of Health

    7. Oct 17, 2012 |Story| Baltimore Sun

  7. Human Genome to lay off 97 workers

    Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...

    Tags: Rockville (Bethlehem, Pennsylvania), Job Layoffs, Career and Workplace, Labor Legislation, Layoffs and Downsizing

    8. Sep 5, 2012 |Story| Baltimore Sun

  8. Human Genome Sciences announces plan to lay off 114

    Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline. Human Genome, which employs about 1,000 people in Rockville, could...

    Tags: Rockville (Bethlehem, Pennsylvania), Job Layoffs, Career and Workplace, Labor Legislation, Layoffs and Downsizing

    9. Jul 16, 2012 |Story| Baltimore Sun

  9. GlaxoSmithKline to acquire Human Genome Sciences

    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion. GlaxoSmithKline boosted its offer for...

    Tags: Drugs and Medicines, Technology, Medical Research, MedImmune Inc., Diabetes

    10. Jul 2, 2012 |Story| Los Angeles Times

  10. GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says

    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil, Wellbutrin and Advair, the U.S. government announced.
    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...

    Tags: Steve Jobs, Judges, Justice System, Diabetes, Companies and Corporations

    11. Jun 8, 2012 |Story| Baltimore Sun

  11. Ripley's opens Odditorium at Harborplace

    Ripley's Believe It or Not, one of the first of several new tenants opening for the summer tourist season at Harborplace in downtown Baltimore, will open Saturday in the Light Street Pavilion. Ripley Entertainment Inc. said exhibits at the Inner Harbor...

    Tags: Oaktree Capital Management, Inner Harbor, Harry Potter (fictional character), Kevin J. Carey, Judges

    12. Apr 21, 2012 |Story| Baltimore Sun

  12. Consolidation wave poised to hit state's health care services, biopharma sectors

    Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals. Both homegrown companies — Human Genome Sciences Inc. and Catalyst...

    Tags: Stock Market, Montgomery (Kane, Illinois), Cigna Corporation, MedImmune Inc., Rockville (Bethlehem, Pennsylvania)

 1  2 • Next >
Original site for Human Genome Sciences Inc. topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Human Genome Sciences Inc. Photos
A bottle of Xenical, a weight-loss aid made by GlaxoSmi...
(May 9, 2012)
GlaxoSmithKline launches hostile tender offer for Human Genome Sciences